{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:48:56Z","timestamp":1793137736660,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Safe and noninvasive methods for breast cancer screening with improved accuracy are urgently needed. Volatile organic compounds (VOCs) in biological samples such as breath and blood have been investigated as noninvasive novel markers of cancer. We investigated volatile organic compounds in urine to assess their potential for the detection of breast cancer. One hundred and ten women with biopsy-proven breast cancer and 177 healthy volunteers were enrolled. The subjects were divided into two groups: a training set and an external validation set. Urine samples were collected and analyzed by gas chromatography and mass spectrometry. A predictive model was constructed by multivariate analysis, and the sensitivity and specificity of the model were confirmed using both a training set and an external set with reproducibility tests. The training set included 60 breast cancer patients (age 34\u201388\u00a0years, mean 60.3) and 60 healthy controls (age 34\u201381\u00a0years, mean 58.7). The external validation set included 50 breast cancer patients (age 35\u201385\u00a0years, mean 58.8) and 117 healthy controls (age 18\u201384\u00a0years, mean 51.2). One hundred and ninety-one compounds detected in at least 80% of the samples from the training set were used for further analysis. The predictive model that best-detected breast cancer at various clinical stages was constructed using a combination of two of the compounds, 2-propanol and 2-butanone. The sensitivity and specificity in the training set were 93.3% and 83.3%, respectively. Triplicated reproducibility tests were performed by randomly choosing ten samples from each group, and the results showed a matching rate of 100% for the breast cancer patient group and 90% for the healthy control group. Our prediction model using two VOCs is a useful complement to the current diagnostic tools. Further studies inclusive of benign tumors and non-breast malignancies are warranted.<\/jats:p>","DOI":"10.1038\/s41598-021-99396-5","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T15:41:58Z","timestamp":1633448518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["A prediction model using 2-propanol and 2-butanone in urine distinguishes breast cancer"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9536-9438","authenticated-orcid":false,"given":"Shoko","family":"Kure","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sera","family":"Satoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Kitayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"key":"99396_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","author":"HG Sung","year":"2020","unstructured":"Sung, H. G. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. https:\/\/doi.org\/10.3322\/caac.21660 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"99396_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejca.2017.11.002","volume":"90","author":"P Autier","year":"2018","unstructured":"Autier, P. & Boniol, M. Mammography screening: A major issue in medicine. Eur. J. Cancer 90, 34\u201362. https:\/\/doi.org\/10.1016\/j.ejca.2017.11.002 (2018).","journal-title":"Eur. J. Cancer"},{"key":"99396_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.7326\/0003-4819-151-10-200911170-00009","volume":"151","author":"HD Nelson","year":"2009","unstructured":"Nelson, H. D. et al. Screening for breast cancer: An update for the U.S. preventive services task force. Ann. Intern. Med. 151, 727\u2013737. https:\/\/doi.org\/10.7326\/0003-4819-151-10-200911170-00009 (2009).","journal-title":"Ann. Intern. Med."},{"issue":"Suppl 1","key":"99396_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1258\/jms.2012.012080","volume":"19","author":"S Njor","year":"2012","unstructured":"Njor, S. et al. Breast cancer mortality in mammographic screening in Europe: A review of incidence-based mortality studies. J. Med. Screen. 19(Suppl 1), 33\u201341. https:\/\/doi.org\/10.1258\/jms.2012.012080 (2012).","journal-title":"J. Med. Screen."},{"key":"99396_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1370\/afm.1466","volume":"11","author":"J Brodersen","year":"2013","unstructured":"Brodersen, J. & Siersma, V. D. Long-term psychosocial consequences of false-positive screening mammography. Ann. Fam. Med. 11, 106\u2013115. https:\/\/doi.org\/10.1370\/afm.1466 (2013).","journal-title":"Ann. Fam. Med."},{"key":"99396_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s12282-008-0082-8","volume":"16","author":"E Tohno","year":"2009","unstructured":"Tohno, E., Ueno, E. & Watanabe, H. Ultrasound screening of breast cancer. Breast Cancer (Tokyo, Japan) 16, 18\u201322. https:\/\/doi.org\/10.1007\/s12282-008-0082-8 (2009).","journal-title":"Breast Cancer (Tokyo, Japan)"},{"key":"99396_CR7","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1093\/clinchem\/31.8.1278","volume":"31","author":"SM Gordon","year":"1985","unstructured":"Gordon, S. M., Szidon, J. P., Krotoszynski, B. K., Gibbons, R. D. & O\u2019Neill, H. J. Volatile organic compounds in exhaled air from patients with lung cancer. Clin. Chem. 31, 1278\u20131282. https:\/\/doi.org\/10.1093\/clinchem\/31.8.1278 (1985).","journal-title":"Clin. Chem."},{"key":"99396_CR8","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1136\/thx.2008.099465","volume":"64","author":"M Westhoff","year":"2009","unstructured":"Westhoff, M. et al. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: Results of a pilot study. Thorax 64, 744\u2013748. https:\/\/doi.org\/10.1136\/thx.2008.099465 (2009).","journal-title":"Thorax"},{"key":"99396_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/cbm-2012-00270","volume":"11","author":"Y Wang","year":"2012","unstructured":"Wang, Y. et al. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. Cancer Biomark.: Sect. A Dis. Mark. 11, 129\u2013137. https:\/\/doi.org\/10.3233\/cbm-2012-00270 (2012).","journal-title":"Cancer Biomark.: Sect. A Dis. Mark."},{"key":"99396_CR10","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.lungcan.2009.11.003","volume":"68","author":"A D'Amico","year":"2010","unstructured":"D\u2019Amico, A. et al. An investigation on electronic nose diagnosis of lung cancer. Lung Cancer 68, 170\u2013176. https:\/\/doi.org\/10.1016\/j.lungcan.2009.11.003 (2010).","journal-title":"Lung Cancer"},{"key":"99396_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/bjs.8942","volume":"100","author":"DF Altomare","year":"2013","unstructured":"Altomare, D. F. et al. Exhaled volatile organic compounds identify patients with colorectal cancer. Br. J. Surg 100, 144\u2013150. https:\/\/doi.org\/10.1002\/bjs.8942 (2013).","journal-title":"Br. J. Surg"},{"key":"99396_CR12","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1136\/gutjnl-2014-308536","volume":"65","author":"H Amal","year":"2016","unstructured":"Amal, H. et al. Detection of precancerous gastric lesions and gastric cancer through exhaled breath. Gut 65, 400\u2013407. https:\/\/doi.org\/10.1136\/gutjnl-2014-308536 (2016).","journal-title":"Gut"},{"key":"99396_CR13","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/bjc.2013.44","volume":"108","author":"ZQ Xu","year":"2013","unstructured":"Xu, Z. Q. et al. A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions. Br. J. Cancer 108, 941\u2013950. https:\/\/doi.org\/10.1038\/bjc.2013.44 (2013).","journal-title":"Br. J. Cancer"},{"key":"99396_CR14","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1158\/1055-9965.EPI-10-0302","volume":"19","author":"T Qin","year":"2010","unstructured":"Qin, T. et al. The screening of volatile markers for hepatocellular carcinoma. Cancer Epidemiol., Biomark. Prev.: Publ. Am. Assoc. Cancer Res., Cospons. Am. Soc. Prev. Oncol. 19, 2247\u20132253. https:\/\/doi.org\/10.1158\/1055-9965.EPI-10-0302 (2010).","journal-title":"Cancer Epidemiol., Biomark. Prev.: Publ. Am. Assoc. Cancer Res., Cospons. Am. Soc. Prev. Oncol."},{"key":"99396_CR15","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/lary.24463","volume":"124","author":"N Leunis","year":"2014","unstructured":"Leunis, N. et al. Application of an electronic nose in the diagnosis of head and neck cancer. Laryngoscope 124, 1377\u20131381. https:\/\/doi.org\/10.1002\/lary.24463 (2014).","journal-title":"Laryngoscope"},{"key":"99396_CR16","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/bjc.2011.128","volume":"104","author":"M Hakim","year":"2011","unstructured":"Hakim, M. et al. Diagnosis of head-and-neck cancer from exhaled breath. Br. J. Cancer 104, 1649\u20131655. https:\/\/doi.org\/10.1038\/bjc.2011.128 (2011).","journal-title":"Br. J. Cancer"},{"key":"99396_CR17","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/bjc.2014.361","volume":"111","author":"M Gruber","year":"2014","unstructured":"Gruber, M. et al. Analysis of exhaled breath for diagnosing head and neck squamous cell carcinoma: A feasibility study. Br. J. Cancer 111, 790\u2013798. https:\/\/doi.org\/10.1038\/bjc.2014.361 (2014).","journal-title":"Br. J. Cancer"},{"key":"99396_CR18","doi-asserted-by":"publisher","first-page":"E614","DOI":"10.1002\/ijc.29166","volume":"136","author":"H Amal","year":"2015","unstructured":"Amal, H. et al. Assessment of ovarian cancer conditions from exhaled breath. Int. J. Cancer 136, E614-622. https:\/\/doi.org\/10.1002\/ijc.29166 (2015).","journal-title":"Int. J. Cancer"},{"key":"99396_CR19","doi-asserted-by":"publisher","first-page":"016004","DOI":"10.1088\/1752-7163\/aa549b","volume":"11","author":"M Phillips","year":"2017","unstructured":"Phillips, M., Cataneo, R. N., Lebauer, C., Mundada, M. & Saunders, C. Breath mass ion biomarkers of breast cancer. J. Breath Res. 11, 016004. https:\/\/doi.org\/10.1088\/1752-7163\/aa549b (2017).","journal-title":"J. Breath Res."},{"key":"99396_CR20","doi-asserted-by":"publisher","first-page":"44864","DOI":"10.18632\/oncotarget.6269","volume":"6","author":"O Barash","year":"2015","unstructured":"Barash, O. et al. Differentiation between genetic mutations of breast cancer by breath volatolomics. Oncotarget 6, 44864\u201344876. https:\/\/doi.org\/10.18632\/oncotarget.6269 (2015).","journal-title":"Oncotarget"},{"key":"99396_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10549-018-4764-4","volume":"170","author":"M Phillips","year":"2018","unstructured":"Phillips, M. et al. Prediction of breast cancer risk with volatile biomarkers in breath. Breast Cancer Res. Treat. 170, 343\u2013350. https:\/\/doi.org\/10.1007\/s10549-018-4764-4 (2018).","journal-title":"Breast Cancer Res. Treat."},{"key":"99396_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10549-006-9176-1","volume":"99","author":"M Phillips","year":"2006","unstructured":"Phillips, M. et al. Prediction of breast cancer using volatile biomarkers in the breath. Breast Cancer Res. Treat. 99, 19\u201321. https:\/\/doi.org\/10.1007\/s10549-006-9176-1 (2006).","journal-title":"Breast Cancer Res. Treat."},{"key":"99396_CR23","doi-asserted-by":"publisher","first-page":"e90226","DOI":"10.1371\/journal.pone.0090226","volume":"9","author":"M Phillips","year":"2014","unstructured":"Phillips, M. et al. Rapid point-of-care breath test for biomarkers of breast cancer and abnormal mammograms. PLoS ONE 9, e90226. https:\/\/doi.org\/10.1371\/journal.pone.0090226 (2014).","journal-title":"PLoS ONE"},{"key":"99396_CR24","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7155\/4\/2\/026003","author":"M Phillips","year":"2010","unstructured":"Phillips, M. Volatile biomarkers in the breath of women with breast cancer. J. Breath Res. https:\/\/doi.org\/10.1088\/1752-7155\/4\/2\/026003 (2010).","journal-title":"J. Breath Res."},{"key":"99396_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1046\/j.1524-4741.2003.09309.x","volume":"9","author":"M Phillips","year":"2003","unstructured":"Phillips, M. et al. Volatile markers of breast cancer in the breath. Breast J. 9, 184\u2013191 (2003).","journal-title":"Breast J."},{"key":"99396_CR26","first-page":"730","volume":"83","author":"M Mangler","year":"2012","unstructured":"Mangler, M. et al. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting. Ginekol. Pol. 83, 730\u2013736 (2012).","journal-title":"Ginekol. Pol."},{"key":"99396_CR27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1271\/bbb.110760","volume":"76","author":"Y Hanai","year":"2012","unstructured":"Hanai, Y. et al. Urinary volatile compounds as biomarkers for lung cancer. Biosci. Biotechnol. Biochem. 76, 679\u2013684. https:\/\/doi.org\/10.1271\/bbb.110760 (2012).","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"99396_CR28","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/annonc\/mdx308","volume":"28","author":"G Curigliano","year":"2017","unstructured":"Curigliano, G. et al. De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen international expert consensus conference on the primary therapy of early breast cancer 2017. Ann. Oncol. 28, 1700\u20131712. https:\/\/doi.org\/10.1093\/annonc\/mdx308 (2017).","journal-title":"Ann. Oncol."},{"key":"99396_CR29","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1073\/pnas.68.10.2374","volume":"68","author":"L Pauling","year":"1971","unstructured":"Pauling, L., Robinson, A. B., Teranishi, R. & Cary, P. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc. Natl. Acad. Sci. U.S.A. 68, 2374\u20132376. https:\/\/doi.org\/10.1073\/pnas.68.10.2374 (1971).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"99396_CR30","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41416-019-0585-4","volume":"121","author":"AR Lima","year":"2019","unstructured":"Lima, A. R. et al. Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine. Br. J. Cancer 121, 857\u2013868. https:\/\/doi.org\/10.1038\/s41416-019-0585-4 (2019).","journal-title":"Br. J. Cancer"},{"key":"99396_CR31","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1111\/jcmm.13132","volume":"21","author":"M Monteiro","year":"2017","unstructured":"Monteiro, M. et al. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients. J. Cell. Mol. Med. 21, 2092\u20132105. https:\/\/doi.org\/10.1111\/jcmm.13132 (2017).","journal-title":"J. Cell. Mol. Med."},{"key":"99396_CR32","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1016\/s0140-6736(98)07552-7","volume":"353","author":"M Phillips","year":"1999","unstructured":"Phillips, M. et al. Volatile organic compounds in breath as markers of lung cancer: A cross-sectional study. Lancet (London, England) 353, 1930\u20131933. https:\/\/doi.org\/10.1016\/s0140-6736(98)07552-7 (1999).","journal-title":"Lancet (London, England)"},{"key":"99396_CR33","doi-asserted-by":"publisher","first-page":"110060","DOI":"10.1016\/j.mehy.2020.110060","volume":"143","author":"R Becker","year":"2020","unstructured":"Becker, R. Non-invasive cancer detection using volatile biomarkers: Is urine superior to breath?. Med. Hypotheses 143, 110060. https:\/\/doi.org\/10.1016\/j.mehy.2020.110060 (2020).","journal-title":"Med. Hypotheses"},{"key":"99396_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.aca.2018.04.027","volume":"1023","author":"P Porto-Figueira","year":"2018","unstructured":"Porto-Figueira, P., Pereira, J. A. M. & C\u00e2mara, J. S. Exploring the potential of needle trap microextraction combined with chromatographic and statistical data to discriminate different types of cancer based on urinary volatomic biosignature. Anal. Chim. Acta 1023, 53\u201363. https:\/\/doi.org\/10.1016\/j.aca.2018.04.027 (2018).","journal-title":"Anal. Chim. Acta"},{"key":"99396_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-019-1525-2","author":"CL Silva","year":"2019","unstructured":"Silva, C. L. Implementing a central composite design for the optimization of solid phase microextraction to establish the urinary volatomic expression: A first approach for breast cancer. Metabolomics https:\/\/doi.org\/10.1007\/s11306-019-1525-2 (2019).","journal-title":"Metabolomics"},{"key":"99396_CR36","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.talanta.2011.12.041","volume":"89","author":"CL Silva","year":"2012","unstructured":"Silva, C. L., Passos, M. & C\u00e2mara, J. S. Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers\u2014A powerful strategy for breast cancer diagnosis. Talanta 89, 360\u2013368. https:\/\/doi.org\/10.1016\/j.talanta.2011.12.041 (2012).","journal-title":"Talanta"},{"key":"99396_CR37","doi-asserted-by":"publisher","first-page":"027103","DOI":"10.1088\/1752-7155\/9\/2\/027103","volume":"9","author":"K Schallschmidt","year":"2015","unstructured":"Schallschmidt, K. et al. In vitro cultured lung cancer cells are not suitable for animal-based breath biomarker detection. J. Breath Res. 9, 027103. https:\/\/doi.org\/10.1088\/1752-7155\/9\/2\/027103 (2015).","journal-title":"J. Breath Res."},{"key":"99396_CR38","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1007\/s10620-015-3596-x","volume":"60","author":"U Navaneethan","year":"2015","unstructured":"Navaneethan, U. et al. Volatile organic compounds in urine for noninvasive diagnosis of malignant biliary strictures: A pilot study. Dig. Dis. Sci. 60, 2150\u20132157. https:\/\/doi.org\/10.1007\/s10620-015-3596-x (2015).","journal-title":"Dig. Dis. Sci."},{"key":"99396_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1754-6834-7-44","volume":"7","author":"X Guo","year":"2014","unstructured":"Guo, X. et al. Effect of the inactivation of lactate dehydrogenase, ethanol dehydrogenase, and phosphotransacetylase on 2,3-butanediol production in Klebsiella pneumoniae strain. Biotechnol. Biofuels 7, 44. https:\/\/doi.org\/10.1186\/1754-6834-7-44 (2014).","journal-title":"Biotechnol. Biofuels"},{"key":"99396_CR40","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.4014\/jmb.1201.01044","volume":"22","author":"B Kim","year":"2012","unstructured":"Kim, B. et al. Enhanced 2,3-butanediol production in recombinant Klebsiella pneumoniae via overexpression of synthesis-related genes. J. Microbiol. Biotechnol. 22, 1258\u20131263. https:\/\/doi.org\/10.4014\/jmb.1201.01044 (2012).","journal-title":"J. Microbiol. Biotechnol."},{"key":"99396_CR41","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jbiosc.2013.02.021","volume":"116","author":"DK Kim","year":"2013","unstructured":"Kim, D. K. et al. Metabolic engineering of a novel Klebsiella oxytoca strain for enhanced 2,3-butanediol production. J. Biosci. Bioeng. 116, 186\u2013192. https:\/\/doi.org\/10.1016\/j.jbiosc.2013.02.021 (2013).","journal-title":"J. Biosci. Bioeng."},{"key":"99396_CR42","doi-asserted-by":"publisher","first-page":"046007","DOI":"10.1088\/1752-7155\/10\/4\/046007","volume":"10","author":"K Schallschmidt","year":"2016","unstructured":"Schallschmidt, K. et al. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study. J. Breath Res. 10, 046007. https:\/\/doi.org\/10.1088\/1752-7155\/10\/4\/046007 (2016).","journal-title":"J. Breath Res."},{"issue":"243","key":"99396_CR43","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1016\/j.urolonc.2017.12.026","volume":"36","author":"A Jimenez-Pacheco","year":"2018","unstructured":"Jimenez-Pacheco, A. et al. Furan and p-xylene as candidate biomarkers for prostate cancer. Urol. Oncol. 36(243), e221-243 e227. https:\/\/doi.org\/10.1016\/j.urolonc.2017.12.026 (2018).","journal-title":"Urol. Oncol."},{"key":"99396_CR44","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10238-016-0408-3","volume":"17","author":"K Orywal","year":"2017","unstructured":"Orywal, K. & Szmitkowski, M. Alcohol dehydrogenase and aldehyde dehydrogenase in malignant neoplasms. Clin. Exp. Med. 17, 131\u2013139. https:\/\/doi.org\/10.1007\/s10238-016-0408-3 (2017).","journal-title":"Clin. Exp. Med."},{"key":"99396_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1079\/pns2003327","volume":"63","author":"DW Crabb","year":"2004","unstructured":"Crabb, D. W., Matsumoto, M., Chang, D. & You, M. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc. Nutr. Soc. 63, 49\u201363. https:\/\/doi.org\/10.1079\/pns2003327 (2004).","journal-title":"Proc. Nutr. Soc."},{"key":"99396_CR46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cca.2014.04.030","volume":"436","author":"J Li","year":"2014","unstructured":"Li, J. et al. Investigation of potential breath biomarkers for the early diagnosis of breast cancer using gas chromatography-mass spectrometry. Clin. Chim. Acta 436, 59\u201367. https:\/\/doi.org\/10.1016\/j.cca.2014.04.030 (2014).","journal-title":"Clin. Chim. Acta"},{"key":"99396_CR47","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1038\/srep05383","volume":"4","author":"C Wang","year":"2014","unstructured":"Wang, C. et al. Volatile organic metabolites identify patients with breast cancer, cyclomastopathy, and mammary gland fibroma. Sci. Rep. 4, 5383. https:\/\/doi.org\/10.1038\/srep05383 (2014).","journal-title":"Sci. Rep."},{"key":"99396_CR48","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1177\/000313481107700632","volume":"77","author":"SG Patterson","year":"2011","unstructured":"Patterson, S. G. et al. Breath analysis by mass spectrometry: A new tool for breast cancer detection?. Am. Surg. 77, 747\u2013751 (2011).","journal-title":"Am. Surg."},{"key":"99396_CR49","doi-asserted-by":"publisher","first-page":"43969","DOI":"10.1038\/srep43969","volume":"7","author":"CL Silva","year":"2017","unstructured":"Silva, C. L., Perestrelo, R., Silva, P., Tomas, H. & Camara, J. S. Volatile metabolomic signature of human breast cancer cell lines. Sci. Rep. 7, 43969. https:\/\/doi.org\/10.1038\/srep43969 (2017).","journal-title":"Sci. Rep."},{"key":"99396_CR50","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1007\/s00216-018-1103-x","volume":"410","author":"C Cavaco","year":"2018","unstructured":"Cavaco, C. Screening of salivary volatiles for putative breast cancer discrimination: An exploratory study involving geographically distant populations. Anal. Bioanal. Chem. 410, 4459\u20134468. https:\/\/doi.org\/10.1007\/s00216-018-1103-x (2018).","journal-title":"Anal. Bioanal. Chem."},{"key":"99396_CR51","doi-asserted-by":"publisher","first-page":"046009","DOI":"10.1088\/1752-7163\/aba83f","volume":"14","author":"LD de Leon-Martinez","year":"2020","unstructured":"de Leon-Martinez, L. D. et al. Identification of profiles of volatile organic compounds in exhaled breath by means of an electronic nose as a proposal for a screening method for breast cancer: A case-control study. J. Breath Res. 14, 046009. https:\/\/doi.org\/10.1088\/1752-7163\/aba83f (2020).","journal-title":"J. Breath Res."},{"key":"99396_CR52","doi-asserted-by":"publisher","first-page":"e23526","DOI":"10.1002\/jcla.23526","volume":"34","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Early diagnosis of breast cancer from exhaled breath by gas chromatography-mass spectrometry (GC\/MS) analysis: A prospective cohort study. J. Clin. Lab. Anal. 34, e23526. https:\/\/doi.org\/10.1002\/jcla.23526 (2020).","journal-title":"J. Clin. Lab. Anal."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99396-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99396-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99396-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:17:23Z","timestamp":1670084243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99396-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["99396"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-99396-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,5]]},"assertion":[{"value":"8 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19801"}}